🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9 results for “Seqirus (Australia) Pty Ltd” Clear

  1. Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)

    Seqirus (Australia) Pty Ltd

    Influenza Virus

    phase 3 mab completed

    1 trial

  2. Influenza Virus Vaccine

    Seqirus (Australia) Pty Ltd

    Influenza

    phase 3 mab completed

    1 trial

  3. Investigational aQIVc

    Seqirus (Australia) Pty Ltd

    Influenza, Human

    phase 3 mab completed

    1 trial

  4. MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)

    Seqirus (Australia) Pty Ltd

    Influenza

    phase 3 mab completed

    1 trial

  5. QIVc

    Seqirus (Australia) Pty Ltd

    Influenza, Human

    phase 3 mab completed

    1 trial

  6. aQIV or aTIV

    Seqirus (Australia) Pty Ltd

    Influenza, Human

    phase 3 mab active

    1 trial

  7. H5N1 antigen combined with MF59 adjuvant

    Seqirus (Australia) Pty Ltd

    Influenza, Human

    phase 2 mab completed

    1 trial

  8. Trivalent influenza vaccine (TIVc)

    Seqirus (Australia) Pty Ltd

    Influenza

    phase 2 mab completed

    1 trial

  9. CSL Limited Influenza Vaccine

    Seqirus (Australia) Pty Ltd

    Influenza

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources